Stephen S. Yoder - Net Worth and Insider Trading
Stephen S. Yoder Net Worth
The estimated net worth of Stephen S. Yoder is at least $1,274 dollars as of 2024-09-20. Stephen S. Yoder is the President and CEO of Pieris Pharmaceuticals Inc and owns about 75 shares of Pieris Pharmaceuticals Inc (PIRS) stock worth over $1,274. Details can be seen in Stephen S. Yoder's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Stephen S. Yoder has not made any transactions after 2016-06-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Stephen S. Yoder
Stephen S. Yoder Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Stephen S. Yoder owns 1 companies in total, including Pieris Pharmaceuticals Inc (PIRS) .
Click here to see the complete history of Stephen S. Yoder’s form 4 insider trades.
Insider Ownership Summary of Stephen S. Yoder
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2016-06-13 | director & President and CEO |
Stephen S. Yoder Latest Holdings Summary
Stephen S. Yoder currently owns a total of 1 stock. Stephen S. Yoder owns 75 shares of Pieris Pharmaceuticals Inc (PIRS) as of June 13, 2016, with a value of $1,274.
Latest Holdings of Stephen S. Yoder
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| PIRS | Pieris Pharmaceuticals Inc | 2016-06-13 | 75 | 16.99 | 1,274 |
Holding Weightings of Stephen S. Yoder
Stephen S. Yoder Form 4 Trading Tracker
According to the SEC Form 4 filings, Stephen S. Yoder has made a total of 0 transactions in Pieris Pharmaceuticals Inc (PIRS) over the past 5 years. The most-recent trade in Pieris Pharmaceuticals Inc is the acquisition of 75 shares on June 13, 2016, which cost Stephen S. Yoder around $10,080.
Insider Trading History of Stephen S. Yoder
- 1
Stephen S. Yoder Trading Performance
GuruFocus tracks the stock performance after each of Stephen S. Yoder's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Stephen S. Yoder is -8.28%. GuruFocus also compares Stephen S. Yoder's trading performance to market benchmark return within the same time period. The performance of stocks bought by Stephen S. Yoder within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Stephen S. Yoder's insider trading performs compared to the benchmark.
Performance of Stephen S. Yoder
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.37 | | | | | |
| Relative Return to S&P 500(%) | -1.16 | | | | | |
Stephen S. Yoder Ownership Network
Stephen S. Yoder Owned Company Details
What does Pieris Pharmaceuticals Inc do?
Who are the key executives at Pieris Pharmaceuticals Inc?
Stephen S. Yoder is the director & President and CEO of Pieris Pharmaceuticals Inc. Other key executives at Pieris Pharmaceuticals Inc include 10 percent owner Bvf Gp Holdings Llc , other: See Explanation of Responses Bvf Ii Gp Llc , and 10 percent owner Bvf I Gp Llc .
Pieris Pharmaceuticals Inc (PIRS) Insider Trades Summary
Over the past 18 months, Stephen S. Yoder made no insider transaction in Pieris Pharmaceuticals Inc (PIRS). Other recent insider transactions involving Pieris Pharmaceuticals Inc (PIRS) include a net purchase of 10,000 shares made by Christopher P Kiritsy , and a net purchase of 6,000 shares made by .
In summary, during the past 3 months, insiders sold 0 shares of Pieris Pharmaceuticals Inc (PIRS) in total and bought 6,000 shares, with a net purchase of 6,000 shares. During the past 18 months, 0 shares of Pieris Pharmaceuticals Inc (PIRS) were sold and 6,125 shares were bought by its insiders, resulting in a net purchase of 6,125 shares.
Pieris Pharmaceuticals Inc (PIRS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Pieris Pharmaceuticals Inc Insider Transactions
Stephen S. Yoder Mailing Address
Above is the net worth, insider trading, and ownership report for Stephen S. Yoder. You might contact Stephen S. Yoder via mailing address: Lise-meitner-strasse 30, C/o Pieris Pharmaceuticals, Inc., Freising-weihenstephan 2m 85354.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
